Literature DB >> 748095

Serum glycoproteins in the liver diseases. VI. The presence of desialylated glycoprotein binding activity in particulate fraction of human liver homogenate.

T Arima, T Kondo, H Nagashima.   

Abstract

The human liver as well as rat liver particulate fraction was determined to have an ability to bind desialylated alpha 1-acid glycoprotein. The binding activity of human liver was the same order of the rat one. A more increased amount of binding of desialylated glycoprotein was found in a new born liver than an adult one. Serum obtained from a cirrhotic patient inhibited the binding. The sucrose density gradient centrifugation revealed that the activity located partly in fractions in which a membrane enzyme, alkaline phosphatase, was detected. The binding activity was a linear function of concentration of human liver particulate fraction added to incubation mixture.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 748095

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  11 in total

1.  Further studies on an eleventh case of heavy (Hgamma1) chain disease--physico-chemical studies.

Authors:  T Arima; C Miyamoto-Sudo; M Hiroata; T Tanigawa; S Tsuboi
Journal:  Acta Med Okayama       Date:  1975-06       Impact factor: 0.892

2.  Serum glycoproteins in the liver diseases. I. Studies on sialic acid-free glycoproteins-improved competitive binding assay of desialylated glycoprotein by rat liver plasma membrane.

Authors:  T Arima; Y Motoyama; K Nagata; T Kondo
Journal:  Gastroenterol Jpn       Date:  1976

3.  Chemical and physical properties of an hepatic membrane protein that specifically binds asialoglycoproteins.

Authors:  T Kawasaki; G Ashwell
Journal:  J Biol Chem       Date:  1976-03-10       Impact factor: 5.157

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Serum glycoproteins in the liver diseases. III. Desialylated glycoproteins in the acute hepatitis.

Authors:  T Arima; Y Motoyama; T Yamamoto; K Nagata; T Kondo
Journal:  Gastroenterol Jpn       Date:  1977

6.  The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins.

Authors:  R L Hudgin; W E Pricer; G Ashwell; R J Stockert; A G Morell
Journal:  J Biol Chem       Date:  1974-09-10       Impact factor: 5.157

7.  The binding of desialylated glycoproteins by plasma membranes of rat liver.

Authors:  W E Pricer; G Ashwell
Journal:  J Biol Chem       Date:  1971-08-10       Impact factor: 5.157

8.  The binding of desialylated glycoproteins by plasma membranes of rat liver. Development of a quantitative inhibition assay.

Authors:  L Van Lenten; G Ashwell
Journal:  J Biol Chem       Date:  1972-07-25       Impact factor: 5.157

9.  Subcellular distribution of a mammalian hepatic binding protein specific for asialoglycoproteins.

Authors:  W E Pricer; G Ashwell
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

10.  Serum glycoproteins in the liver diseases. V. Desialylated glycoproteins in chronic hepatitis.

Authors:  T Arima; Y Motoyama; T Yamamoto; K Nagata; T Kondo; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1978
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.